Clinical significance of erythrocyte carbonic anhydrase concentration in different thyroid diseases

PENG Chun-xia,GAO Yan-ming,GAO Ying,WANG Wei,WANG Shu-feng
DOI: https://doi.org/10.3969/j.issn.1004-583x.2007.19.002
2007-01-01
Abstract:Objective Thyroid hormone and erythrocyte carbonic anhydrase(CA) concentration were measured in 38 patients with different thyroid diseases,and the relationship between them was researched.Methods Thirty-eight cases patients were divided into three groups:Graves disease 20,hypothyroidism 10 and Hashitoxicosis 8,healthy adults 28 served as control group.The level of serum triiodothyronine(T3),thyroxine(T4),thyrotropic-stimulating hormone(TSH) and erythrocyte CA were measured once in four weeks for 16 weeks in all the subjects.Results ①The concentration of CA in Graves disease was significantly lower than that of control group in 0,4,8 weeks after treatment(P<0.001),but in the 12th week after treatment,the concentration of CA was in the normal range,there was no significant difference(P>0.05) compared with control group.There was no difference in the concentration of CA between Hashitoxicosis group,hypothyroidism(P>0.05) and their corresponding control groups.② In 0 week,the levels of T3 and T4 were no significant difference between Graves disease and Hashitoxicosis groups(P>0.05).The CA in Graves disease was significantly lower than in Hashitoxicosis group(P<0.05).③In Graves disease,the normalization ratio of T3 and T4 in 4,8 weeks after treatment was higher than that in 0 week(P<0.05) respectively.There was no significant difference on the normalization ratio of CA in 4,8 weeks after treatment compared with that in 0 week(P>0.05) respectively,but it was higher in the 12th week than that in 0 week(P<0.001).Conclusion ①The erythrocyte concentration of CA can be used in the differentiation between Graves disease and Hashitoxicosis.And it could be used to guide therapy in different causes of thyrotoxicosis.②The erythrocyte concentration of CA reflects the mean level of the thyroid hormone measured 8 weeks earlier in the different thyroid diseases.
What problem does this paper attempt to address?